Related Experiment Video
Updated: Aug 16, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Biotransformation in man and clinical toxicity of volatile anesthetics
Abstract:
Delayed toxic reactions following general anesthesia are dependent on biotransformation of ansethetic drugs. Up to ten grams of metabolites of the more extensively metabolized volatile anesthetics may undergo irreversible intracellular binding. This could contribute importantly to the incidence of hepatic necrosis. A second important cause of toxic reactions is production of toxic metabolites. Nephrotoxicity with impairment of urine concentrating ability following methhoxyflurane anesthesia correlates best with blood fluoride levels and total urinary oxalate. A possible role of enzyme induction in hepatic and hepatorenal failure following, fluroxene anesthesia is suggested by recent studies in the monkey, which demonstrate that pretreatment with phenobarbital results in increased production of a toxic metabolite and conversion of a well tolerated anesthesia to a rapidly lethal one. Improvement in the safety to general anesthesia can be expected from either of two developments: production of anesthetics which are resistant to biotransformation, or development of drugs which will inhibit biotrasnformation during and immediately following anesthesia when maximum rates of biotransformation tend to occur. An important additional safeguard will have been achieved when a successful method is found to identify before exposure patients who may susceptible to delayed toxic reactions.
Insights
Delayed toxic reactions from general anesthesia stem from drug metabolism. Strategies to improve anesthetic safety include developing resistant drugs or inhibitors, and identifying susceptible patients.
Area of Science:
- Anesthesiology
- Toxicology
- Pharmacology
Background:
- Delayed toxic reactions after general anesthesia are linked to anesthetic drug biotransformation.
- Metabolites of volatile anesthetics can cause irreversible intracellular binding, potentially leading to hepatic necrosis.
- Toxic metabolite production is another significant cause of adverse anesthetic reactions.
Purpose of the Study:
- To explore the mechanisms of delayed toxic reactions following general anesthesia.
- To identify factors contributing to hepatic necrosis and nephrotoxicity.
- To suggest strategies for improving the safety of general anesthesia.
Main Methods:
- Review of existing literature on anesthetic drug metabolism and toxicity.
- Correlation analysis of nephrotoxicity with blood fluoride and urinary oxalate levels.
- Examination of enzyme induction effects on anesthetic toxicity using animal models.
Main Results:
- Extensively metabolized volatile anesthetics can produce metabolites causing hepatic necrosis.
- Methoxyflurane-induced nephrotoxicity correlates with blood fluoride and urinary oxalate.
- Enzyme induction, demonstrated in monkeys, can increase toxic metabolite production, turning a safe anesthetic into a lethal one.
Conclusions:
- Anesthetic safety can be enhanced by developing biotransformation-resistant anesthetics or inhibitors.
- Identifying patients susceptible to delayed toxic reactions is crucial for improving anesthetic safety.
- Further research into enzyme induction and patient susceptibility is warranted.
More Related Videos
Related Concept Videos
Drug Biotransformation: Overview
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Stages of General Anesthesia
Inhalational Anesthetics: Overview
Drug Biotransformation: Overview
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...

